Dynatronics (NASDAQ:DYNT) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Dynatronics (NASDAQ:DYNTGet Rating) in a report released on Wednesday. The firm set a “hold” rating on the medical equipment provider’s stock.

Several other analysts also recently weighed in on the stock. Roth Capital reissued a “buy” rating on shares of Dynatronics in a research report on Thursday, February 17th. TheStreet downgraded shares of Dynatronics from a “c-” rating to a “d+” rating in a research report on Friday, February 11th. Finally, Zacks Investment Research raised shares of Dynatronics from a “sell” rating to a “hold” rating in a research report on Wednesday, April 13th. Two investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Buy” and a consensus target price of $2.13.

Shares of Dynatronics stock opened at $0.67 on Wednesday. The stock has a 50 day moving average price of $0.73. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.30 and a current ratio of 2.38. Dynatronics has a 52-week low of $0.67 and a 52-week high of $1.79. The stock has a market cap of $12.04 million, a P/E ratio of 7.45 and a beta of -0.06.

Dynatronics (NASDAQ:DYNTGet Rating) last issued its quarterly earnings data on Thursday, February 10th. The medical equipment provider reported ($0.09) earnings per share (EPS) for the quarter. Dynatronics had a return on equity of 12.52% and a net margin of 4.50%. The firm had revenue of $10.53 million during the quarter. During the same quarter in the prior year, the firm posted ($0.06) earnings per share. As a group, equities research analysts expect that Dynatronics will post -0.21 earnings per share for the current fiscal year.

Hedge funds have recently added to or reduced their stakes in the company. Citadel Advisors LLC purchased a new stake in shares of Dynatronics in the 3rd quarter valued at $30,000. Goldman Sachs Group Inc. acquired a new position in shares of Dynatronics in the 3rd quarter valued at $56,000. Millennium Management LLC acquired a new position in Dynatronics during the third quarter worth $120,000. Finally, Renaissance Technologies LLC raised its position in Dynatronics by 36.8% during the fourth quarter. Renaissance Technologies LLC now owns 1,096,365 shares of the medical equipment provider’s stock worth $1,096,000 after acquiring an additional 295,200 shares during the period. 9.95% of the stock is currently owned by institutional investors and hedge funds.

Dynatronics Company Profile (Get Rating)

Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. Its orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products.

Featured Articles

Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with MarketBeat.com's FREE daily email newsletter.